Cargando…
Overcoming Immune Evasion in Melanoma
Melanoma is the most aggressive and dangerous form of skin cancer that develops from transformed melanocytes. It is crucial to identify melanoma at its early stages, in situ, as it is “curable” at this stage. However, after metastasis, it is difficult to treat and the five-year survival is only 25%....
Autores principales: | Eddy, Kevinn, Chen, Suzie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730443/ https://www.ncbi.nlm.nih.gov/pubmed/33256089 http://dx.doi.org/10.3390/ijms21238984 |
Ejemplares similares
-
Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma
por: Eddy, Kevinn, et al.
Publicado: (2021) -
Biology, Therapy and Implications of Tumor Exosomes in the Progression of Melanoma
por: Isola, Allison L., et al.
Publicado: (2016) -
Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities
por: Eddy, Kevinn, et al.
Publicado: (2021) -
Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness
por: Isola, Allison L., et al.
Publicado: (2017) -
Overcoming tumor immune evasion with an unique arbovirus
por: Lyday, Bruce, et al.
Publicado: (2015)